From e134f1f0c87f88e697242b7170dd0014991f951a Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Wed, 18 Mar 2026 15:57:25 +0000 Subject: [PATCH] auto-fix: strip 2 broken wiki links Pipeline auto-fixer: removed [[ ]] brackets from links that don't resolve to existing claims in the knowledge base. --- ...tions-because-10-year-window-excludes-long-term-savings.md | 4 ++-- 1 file changed, 2 insertions(+), 2 deletions(-) diff --git a/domains/health/federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md b/domains/health/federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md index 3bd226ea..46c0107d 100644 --- a/domains/health/federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md +++ b/domains/health/federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md @@ -41,13 +41,13 @@ The claim that budget scoring "systematically" undervalues prevention requires e ### Additional Evidence (confirm) -*Source: [[2024-11-01-aspe-medicare-anti-obesity-medication-coverage]] | Added: 2026-03-16* +*Source: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage | Added: 2026-03-16* The CBO vs. ASPE divergence on Medicare GLP-1 coverage provides concrete evidence: CBO projects $35B in additional spending (2026-2034) using budget scoring methodology, while ASPE projects net savings of $715M over 10 years using clinical economics methodology that includes downstream event avoidance. The $35.7B gap between these estimates demonstrates how budget scoring rules structurally disadvantage preventive interventions. CBO uses conservative uptake assumptions and doesn't fully count avoided hospitalizations and disease progression within the 10-year window, while ASPE includes 38,950 CV events avoided and 6,180 deaths avoided. Both are technically correct but answer different questions—budget impact vs. clinical economics. ### Additional Evidence (challenge) -*Source: [[2025-01-01-gimm-hoffman-chw-rct-scoping-review]] | Added: 2026-03-18* +*Source: 2025-01-01-gimm-hoffman-chw-rct-scoping-review | Added: 2026-03-18* IMPaCT's $2.47 Medicaid ROI within the same fiscal year demonstrates that at least one category of preventive intervention (CHW programs) generates returns fast enough to be captured within annual budget cycles, not just 10-year windows. This suggests the scoring methodology problem may be less severe for interventions with rapid return profiles.